← feed

Is NCT03846843 results overdue?

Yes — results are overdue. Primary completion was 2017-11-30; the FDAAA-801 reporting deadline (2018-11-30) passed 2760 days ago and no results are posted on ClinicalTrials.gov.

OCR002-SP103 - Oral Immediate Release Study

NCT IDNCT03846843 ↗
SponsorOcera Therapeutics, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-11-30 (ACTUAL)
Reporting deadline2018-11-30 (completion + 365d)
Days overdue2760
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 4afaf505a8e1e1f1… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03846843. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →